The Combination of Metformin and Disulfiram-Cu for Effective Radiosensitization on Glioblastoma Cells
Objective: Glioblastoma (GBM) is one of the devastating types of primary brain tumors with a negligible response to standard therapy. Repurposing drugs, such as disulfiram (DSF) and metformin (Met) have shown antitumor properties in different cell lines, including GBM. In the present study, we foc...
Main Authors: | Narges Rezaei, Ali Neshasteh-Riz, Zohreh Mazaheri, Fereshteh Koosha, Mahmood Hoormand |
---|---|
Format: | Article |
Language: | English |
Published: |
Royan Institute (ACECR), Tehran
2020-10-01
|
Series: | Cell Journal |
Subjects: | |
Online Access: | https://celljournal.org/journal/article/abstract/6798 |
Similar Items
-
Disulfiram in glioma: Literature review of drug repurposing
by: Shiyu Zhong, et al.
Published: (2022-08-01) -
Encephalopathy caused by disulfiram
by: R. Sant’Angelo, et al.
Published: (2021-04-01) -
Disulfiram reaction
by: Banjac Nada, et al.
Published: (2019-01-01) -
Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
by: Vinodh Kannappan, et al.
Published: (2021-09-01) -
Oculogyric Crisis Associated with Disulfiram-Induced Pallidonigral Lesion
by: Jae Hyeok Lee, et al.
Published: (2009-05-01)